Jennison Associates LLC Sutro Biopharma, Inc. Transaction History

Jennison Associates LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 07, 2020	SELL	$8.15 - $11.39 $1.18 Million - $1.64 Million	-144,310 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$7.91 - $11.76 $115,201 - $171,272	-14,564 Reduced 9.17%	144,310 $1.31 Million
Q2 2019 Aug 06, 2019	BUY	$9.69 - $12.23 $204,323 - $257,881	21,086 Added 15.3%	158,874 $0
Q1 2019 May 10, 2019	BUY	$8.8 - $11.87 $41,720 - $56,275	4,741 Added 3.56%	137,788 $1.57 Million
Q4 2018 Feb 06, 2019	SELL	$8.69 - $14.85 $147,321 - $251,752	-16,953 Reduced 11.3%	133,047 $1.2 Million
Q3 2018 Nov 08, 2018	BUY	$15.0 - $15.2 $2.25 Million - $2.28 Million	150,000 New	150,000 $2.25 Million

136

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $105M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.